Social organizations and political institutions: why China and Europe diverged
Economica · 2024-04 · 91 (362) · 347-382
DOI: 10.1111/ecca.12508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Economica, online erschienen am 27.12.2023. Verfasst von Joel Mokyr und 1 weiteren Autor:innen. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This paper discusses the historical and social origins of the bifurcation in the political institutions of China and Western Europe. An important factor, recognized in the literature, is that China centralized state institutions very early on, while Europe remained politically fragmented for much longer. These initial differences, however, were amplified by the different social organizations (clans in China, corporate structures in Europe) that spread in these two societies at the turn of the first millennium AD. State institutions interacted with these organizations, and were shaped and influenced by this interaction. The paper discusses the many ways in which corporate organizations contributed to the emergence of representative institutions and gave prominence to the Rule of Law in the early stages of state formation in Europe, and how specific features of lineage organizations contributed to the consolidation of the Imperial regime in China.
Zitieren
APA
Mokyr, J., & Tabellini, G. (2024). Social organizations and political institutions: why China and Europe diverged. Economica, 91(362), 347-382. https://doi.org/10.1111/ecca.12508
Vancouver
Mokyr J, Tabellini G. Social organizations and political institutions: why China and Europe diverged. Economica. 2024;91(362):347-382. doi:10.1111/ecca.12508
BibTeX
@article{Mokyr2024,
author = {Mokyr, Joel and Tabellini, Guido},
title = {Social organizations and political institutions: why China and Europe diverged},
journal = {Economica},
year = {2024},
volume = {91},
number = {362},
pages = {347--382},
doi = {10.1111/ecca.12508}
}
EUVIMED